Literature DB >> 7636966

Myxoma virus induces extensive CD4 downregulation and dissociation of p56lck in infected rabbit CD4+ T lymphocytes.

M Barry1, S F Lee, L Boshkov, G McFadden.   

Abstract

Myxoma virus is a pathogenic poxvirus that induces extensive dysregulation of cellular immunity in infected European rabbits. Infection of a rabbit CD4+ T-cell line (RL-5) with myxoma virus results in dramatic reductions of cell surface levels of CD4 as monitored by flow cytometry. The virus-induced downregulation of CD4 requires early but not late viral gene expression and could not be inhibited by staurosporine, an inhibitor of protein kinase C, which effectively blocks phorbol 12-myristate-13-acetate-induced downregulation of CD4. The decrease in total cellular levels of CD4 during myxoma virus infection could be inhibited by the lysosomotrophic agent NH4Cl, suggesting a lysosomal fate for CD4 during myxoma virus infection. Steady-state levels of the CD4-associated protein tyrosine kinase p56lck remained unchanged during myxoma virus infection, suggesting that p56lck dissociates from CD4 prior to CD4 degradation in virus infected cells. Total p56lck kinase activity was unaffected during myxoma virus infection, although the amount of p56lck physically associated with CD4 declined in parallel with the loss of CD4. Thus, myxoma virus infection of CD4+ T lymphocytes triggers CD4 downregulation via a protein kinase C-independent pathway, causing the dissociation of p56lck and the degradation of CD4 in lysosomal vesicles.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7636966      PMCID: PMC189357     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  48 in total

1.  A novel di-leucine motif and a tyrosine-based motif independently mediate lysosomal targeting and endocytosis of CD3 chains.

Authors:  F Letourneur; R D Klausner
Journal:  Cell       Date:  1992-06-26       Impact factor: 41.582

Review 2.  Recombinant vaccinia viruses as vectors for studying T lymphocyte specificity and function.

Authors:  J R Bennink; J W Yewdell
Journal:  Curr Top Microbiol Immunol       Date:  1990       Impact factor: 4.291

3.  Phosphorylation-dependent down-modulation of CD4 requires a specific structure within the cytoplasmic domain of CD4.

Authors:  J Shin; R L Dunbrack; S Lee; J L Strominger
Journal:  J Biol Chem       Date:  1991-06-05       Impact factor: 5.157

4.  Effect of myristoylation on p27 nef subcellular distribution and suppression of HIV-LTR transcription.

Authors:  G Yu; R L Felsted
Journal:  Virology       Date:  1992-03       Impact factor: 3.616

5.  Serine phosphorylation-independent downregulation of cell-surface CD4 by nef.

Authors:  J V Garcia; A D Miller
Journal:  Nature       Date:  1991-04-11       Impact factor: 49.962

6.  Kinetics of expression of multiply spliced RNA in early human immunodeficiency virus type 1 infection of lymphocytes and monocytes.

Authors:  M E Klotman; S Kim; A Buchbinder; A DeRossi; D Baltimore; F Wong-Staal
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-01       Impact factor: 11.205

7.  Internalization, lysosomal degradation and new synthesis of surface membrane CD4 in phorbol ester-activated T-lymphocytes and U-937 cells.

Authors:  C M Petersen; E I Christensen; B S Andresen; B K Møller
Journal:  Exp Cell Res       Date:  1992-07       Impact factor: 3.905

Review 8.  Poxvirus pathogenesis.

Authors:  R M Buller; G J Palumbo
Journal:  Microbiol Rev       Date:  1991-03

9.  Human immunodeficiency virus type 1 Vpu protein induces rapid degradation of CD4.

Authors:  R L Willey; F Maldarelli; M A Martin; K Strebel
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

10.  Virus-induced loss of class I MHC antigens from the surface of cells infected with myxoma virus and malignant rabbit fibroma virus.

Authors:  L K Boshkov; J L Macen; G McFadden
Journal:  J Immunol       Date:  1992-02-01       Impact factor: 5.422

View more
  12 in total

Review 1.  Poxvirus immunomodulatory strategies: current perspectives.

Authors:  J B Johnston; Grant McFadden
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

2.  Post-translational modification of the myxoma-virus anti-inflammatory serpin SERP-1 by a virally encoded sialyltransferase.

Authors:  P Nash; M Barry; B T Seet; K Veugelers; S Hota; J Heger; C Hodgkinson; K Graham; R J Jackson; G McFadden
Journal:  Biochem J       Date:  2000-04-15       Impact factor: 3.857

3.  Serp2, an inhibitor of the interleukin-1beta-converting enzyme, is critical in the pathobiology of myxoma virus.

Authors:  F Messud-Petit; J Gelfi; M Delverdier; M F Amardeilh; R Py; G Sutter; S Bertagnoli
Journal:  J Virol       Date:  1998-10       Impact factor: 5.103

4.  Inhibition of retromer activity by herpesvirus saimiri tip leads to CD4 downregulation and efficient T cell transformation.

Authors:  Dior Kingston; Heesoon Chang; Armin Ensser; Hye-Ra Lee; Jongsoo Lee; Sun-Hwa Lee; Jae Ung Jung; Nam-Hyuk Cho
Journal:  J Virol       Date:  2011-08-17       Impact factor: 5.103

5.  M062 is a host range factor essential for myxoma virus pathogenesis and functions as an antagonist of host SAMD9 in human cells.

Authors:  Jia Liu; Sonia Wennier; Leiliang Zhang; Grant McFadden
Journal:  J Virol       Date:  2011-01-19       Impact factor: 5.103

6.  Viruses within the Flaviviridae decrease CD4 expression and inhibit HIV replication in human CD4+ cells.

Authors:  Jinhua Xiang; James H McLinden; Robert A Rydze; Qing Chang; Thomas M Kaufman; Donna Klinzman; Jack T Stapleton
Journal:  J Immunol       Date:  2009-12-15       Impact factor: 5.422

7.  Orthopoxviruses require a functional ubiquitin-proteasome system for productive replication.

Authors:  Alastair Teale; Stephanie Campbell; Nick Van Buuren; Wendy C Magee; Kelly Watmough; Brianne Couturier; Robyn Shipclark; Michele Barry
Journal:  J Virol       Date:  2008-12-24       Impact factor: 5.103

8.  The PHD/LAP-domain protein M153R of myxomavirus is a ubiquitin ligase that induces the rapid internalization and lysosomal destruction of CD4.

Authors:  Mandana Mansouri; Eric Bartee; Kristine Gouveia; Bianca T Hovey Nerenberg; John Barrett; Laurel Thomas; Gary Thomas; Grant McFadden; Klaus Früh
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

9.  Activation of Human T Cells in Hypertension: Studies of Humanized Mice and Hypertensive Humans.

Authors:  Hana A Itani; William G McMaster; Mohamed A Saleh; Rafal R Nazarewicz; Tomasz P Mikolajczyk; Anna M Kaszuba; Anna Konior; Aleksander Prejbisz; Andrzej Januszewicz; Allison E Norlander; Wei Chen; Rachel H Bonami; Andrew F Marshall; Greg Poffenberger; Cornelia M Weyand; Meena S Madhur; Daniel J Moore; David G Harrison; Tomasz J Guzik
Journal:  Hypertension       Date:  2016-05-23       Impact factor: 10.190

Review 10.  Lessons in détente or know thy host: the immunomodulatory gene products of myxoma virus.

Authors:  Martha C Zúñiga
Journal:  J Biosci       Date:  2003-04       Impact factor: 2.795

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.